Group 1 - The core viewpoint of the articles highlights the performance and valuation of Tianchen Medical, which closed at 45.25 yuan, up 6.07%, with a rolling PE ratio of 68.35 times and a total market value of 3.672 billion yuan [1] - The average PE ratio for the medical device industry is 55.91 times, with a median of 40.36 times, positioning Tianchen Medical at the 94th rank within the industry [1] - As of March 31, 2025, Tianchen Medical has 4,443 shareholders, an increase of 68 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Group 2 - Tianchen Medical focuses on the research, innovation, production, and sales of high-end surgical anastomosis devices, with main products including endoscopic anastomosis devices, tubular anastomosis devices, linear cutting anastomosis devices, pouch anastomosis devices, and linear suturing devices [1] - The company has been recognized with the title of "Suzhou Intelligent Workshop - Minimally Invasive Surgical Anastomosis Device Intelligent Manufacturing Workshop" [1] - In the latest quarterly report for Q1 2025, the company achieved an operating income of 65.8461 million yuan, a year-on-year increase of 9.34%, and a net profit of 13.1867 million yuan, a year-on-year increase of 16.16%, with a gross profit margin of 58.46% [1]

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Tianchen Medical, which closed at 42.66 yuan with a 3.42% increase, resulting in a rolling PE ratio of 64.44 times and a total market value of 3.462 billion yuan [1] - The average PE ratio for the medical device industry is 56.95 times, with a median of 40.49 times, positioning Tianchen Medical at the 91st rank within the industry [1] - As of March 31, 2025, Tianchen Medical has 4,443 shareholders, an increase of 68 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Group 2 - Tianchen Medical focuses on the research, innovation, production, and sales of high-end surgical staplers, with key products including endoscopic staplers, tubular staplers, linear cutting staplers, pouch staplers, and linear suturing staplers [1] - The company has been recognized with the title of "Suzhou Intelligent Workshop - Minimally Invasive Surgical Stapler Intelligent Manufacturing Workshop" [1] - In the latest quarterly report for Q1 2025, the company achieved an operating revenue of 65.8461 million yuan, a year-on-year increase of 9.34%, and a net profit of 13.1867 million yuan, reflecting a year-on-year growth of 16.16%, with a gross profit margin of 58.46% [1]

8月14日，天臣医疗今日收盘38.97元，下跌2.18%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到58.86倍，总市值31.63亿元。 股东方面，截至2025年3月31日，天臣医疗股东户数4443户，较上次增加68户，户均持股市值35.28万 元，户均持股数量2.76万股。 天臣国际医疗科技股份有限公司的主营业务是专注于高端外科手术吻合器研发创新和生产销售。公司的 主要产品是腔镜吻合器类、管型吻合器类、线型切割吻合器类、荷包吻合器类、线型缝合吻合器类。公 司曾获得"苏州市级智能车间——微创外科吻合器智能制造车间"称号。 来源：金融界 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均55.76倍，行业中值39.14倍，天臣医疗排 名第89位。 最新一期业绩显示，2025年一季报，公司实现营业收入6584.61万元，同比9.34%；净利润1318.67万 元，同比16.16%，销售毛利率58.46%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13天臣医疗58.8660.945.5331.63亿行业平均 55.7651.784.91117.92亿行业中值39.1439.592 ...

最新一期业绩显示，2025年一季报，公司实现营业收入6584.61万元，同比9.34%；净利润1318.67万 元，同比16.16%，销售毛利率58.46%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13天臣医疗55.8957.865.2530.03亿行业平均 54.7951.294.80116.92亿行业中值37.8638.002.7755.22亿1九安医疗11.1511.280.88188.19亿2英科医疗 15.9217.161.42251.53亿3新华医疗16.1314.951.32103.38亿4振德医疗16.1915.261.0358.78亿5山东药玻 16.2416.291.87153.63亿6奥美医疗16.7216.391.7260.41亿7康德莱17.6917.711.4738.13亿8维力医疗 17.7518.972.2341.62亿9九强生物17.8316.582.1888.30亿10奥泰生物18.5619.571.5059.18亿11鱼跃医疗 20.0419.652.71354.88亿12三鑫医疗20.2720.283.3446.13亿 来源：金融界 8月7日，天臣医疗今 ...

8月4日，天臣医疗今日收盘39.98元，上涨3.28%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到60.39倍，创1139天以来新低，总市值32.45亿元。 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均54.32倍，行业中值38.11倍，天臣医疗排 名第89位。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13天臣医疗60.3962.525.6832.45亿行业平均 54.3250.504.72116.17亿行业中值38.1137.682.7056.52亿1九安医疗10.9911.120.87185.49亿2新华医疗 15.9814.821.30102.47亿3英科医疗16.0817.331.43254.01亿4山东药玻16.1016.151.85152.30亿5振德医疗 16.4615.511.0559.74亿6奥美医疗16.5616.231.7059.84亿7康德莱17.8617.871.4838.48亿8九强生物 17.9416.682.2088.83亿9维力医疗18.0819.322.2742.38亿10奥泰生物18.1519.131.4757.88亿11鱼跃医疗 ...

来源：金融界 天臣国际医疗科技股份有限公司的主营业务是专注于高端外科手术吻合器研发创新和生产销售。公司的 主要产品是腔镜吻合器类、管型吻合器类、线型切割吻合器类、荷包吻合器类、线型缝合吻合器类。公 司曾获得"苏州市级智能车间——微创外科吻合器智能制造车间"称号。 最新一期业绩显示，2025年一季报，公司实现营业收入6584.61万元，同比9.34%；净利润1318.67万 元，同比16.16%，销售毛利率58.46%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13天臣医疗58.0360.085.4531.18亿行业平均 55.1550.114.80115.74亿行业中值37.4836.822.6955.61亿1九安医疗11.0711.200.87186.87亿2英科医疗 14.0715.171.25222.33亿3新华医疗15.9114.751.30101.98亿4振德医疗16.1515.221.0358.62亿5山东药玻 16.2116.261.86153.29亿6奥美医疗16.3215.991.6858.96亿7康德莱17.1917.201.4237.04亿8九强生物 17.5016.272 ...

Group 1 - The core viewpoint of the article highlights the performance and valuation of Tianchen Medical, noting its stock price increase and current market metrics [1] - As of July 28, Tianchen Medical's closing price was 38.29 yuan, with a PE ratio of 57.84, marking a new low in 1133 days, and a total market capitalization of 3.107 billion yuan [1] - The average PE ratio in the medical device industry is 55.28, with a median of 38.06, placing Tianchen Medical at the 88th position in the industry ranking [1] Group 2 - As of March 31, 2025, Tianchen Medical had 4,443 shareholders, an increase of 68 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The company specializes in the research, innovation, production, and sales of high-end surgical staplers, with key products including various types of staplers and suturing devices [1] - The latest quarterly report for Q1 2025 shows that the company achieved a revenue of 65.8461 million yuan, a year-on-year increase of 9.34%, and a net profit of 13.1867 million yuan, up 16.16%, with a gross margin of 58.46% [1]

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Tianchen Medical, which closed at 34.93 yuan with a PE ratio of 52.76 times, and a total market capitalization of 2.835 billion yuan [1] - The average PE ratio for the medical device industry is 54.56 times, with a median of 37.54 times, positioning Tianchen Medical at the 87th rank within the industry [1][2] - As of March 31, 2025, Tianchen Medical has 4,443 shareholders, an increase of 68 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Group 2 - Tianchen Medical specializes in the research, innovation, production, and sales of high-end surgical staplers, with key products including endoscopic staplers, tubular staplers, linear cutting staplers, pouch staplers, and linear suturing staplers [1] - The latest quarterly report for Q1 2025 shows that the company achieved a revenue of 65.8461 million yuan, representing a year-on-year increase of 9.34%, and a net profit of 13.1867 million yuan, reflecting a year-on-year growth of 16.16%, with a gross profit margin of 58.46% [1]

Company Overview - Tianchen Medical closed at 32.75 yuan, up 2.99%, with a rolling PE ratio of 49.47, marking a new low in 1103 days, and a total market value of 2.658 billion yuan [1] - The company specializes in the research, innovation, production, and sales of high-end surgical anastomosis devices, including various types of endoscopic and linear cutting anastomosis devices [1] - As of the first quarter of 2025, seven institutions held shares in Tianchen Medical, with a total holding of 4.481 million shares valued at 0.85 million yuan [1] Financial Performance - For the first quarter of 2025, Tianchen Medical reported revenue of 65.8461 million yuan, a year-on-year increase of 9.34%, and a net profit of 13.1867 million yuan, up 16.16%, with a gross profit margin of 58.46% [1] Industry Comparison - The average PE ratio for the medical device industry is 52.06, with a median of 37.22, placing Tianchen Medical at the 87th position within the industry [1] - The industry average PE ratio is 52.06, while the median is 37.22, indicating that Tianchen Medical's PE ratio is below the industry average but above the median [2]

Company Overview - Tianchen Medical closed at 22.6 yuan, up 3.67%, with a rolling PE ratio of 34.14, marking a new low in 349 days, and a total market value of 1.834 billion yuan [1] - The company specializes in the research, innovation, production, and sales of high-end surgical staplers, with main products including endoscopic staplers, tubular staplers, linear cutting staplers, pouch staplers, and linear suturing staplers [1] - Tianchen Medical was awarded the title of "Suzhou Intelligent Workshop - Minimally Invasive Surgical Stapler Intelligent Manufacturing Workshop" [1] Financial Performance - For Q1 2025, the company reported revenue of 65.8461 million yuan, a year-on-year increase of 9.34%, and a net profit of 13.1867 million yuan, up 16.16%, with a gross profit margin of 58.46% [1] Shareholder Information - As of March 31, 2025, Tianchen Medical had 4,443 shareholders, an increase of 68 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Comparison - The average PE ratio for the medical device industry is 49.40, with a median of 36.13, placing Tianchen Medical at 73rd in the industry ranking [2] - The industry average market value is 10.539 billion yuan, while the median market value is 4.781 billion yuan [2]